The release profile of a controlled release preparation of 5-aminosalicylic acid (Rowasa I®) in humans-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The release profile of a controlled release preparation of 5-aminosalicylic acid (Rowasa I®) in humans

Published:1990-01 Issue:1 Volume:33 Page:21-25
ISSN:0012-3706
Container-title:Diseases of the Colon & Rectum
language:en
Short-container-title:

Author:

McLeod Robin S.,Cohen Zane,Vari Barbara J.,Blair Joan E.,Greenberg Gordon R.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,General Medicine

Reference11 articles.

1. Das KM. Pharmacotherapy of inflammatory bowel disease Part I. Sulfasalazine. Postgrad Med 1983;74:141–54.

2. Azad Khan AK, Piris J, Truelove SC. An experiment to deterrmine the active therapeutic moiety of sulphasalazine. Lancet 1977;2:892–5.

3. Gould SR, Lennard Jones JE. Production of prostaglandins in ulcerative colitis and their inhibition by sulphasalazine. Gut 1976;17:828.

4. Summers RW, Switz DM, Sessions JT Jr,et al. National Cooperative Crohn's Disease Study: results of drug treatment. Gastroenterology 1979;77:847–69.

5. Malchow H, Ewe K, Brandes JW,et al. European Cooperative Crohn's Disease Study: results of drug treatment. Gastroenterology 1984:86:249–66.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review article: new developments in the use of 5-aminosalicylic acid in patients with inflammatory bowel disease;Alimentary Pharmacology & Therapeutics;2007-03-31

2. Is Once-Daily Mesalazine Equivalent to the Currently Used Twice-Daily Regimen? A Study Performed in 30 Healthy Volunteers;The Journal of Clinical Pharmacology;2007-03

3. Enteral Drug Absorption in Patients with Short Small Bowel;Clinical Pharmacokinetics;2004

4. Small intestinal transit time and intraluminal pH in ileocecal resected patients with Crohn's disease;Digestive Diseases and Sciences;1998

5. INTESTINAL FATE OF 5-AMINOSALICYLIC ACID: REGIONAL AND SYSTEMIC KINETIC STUDIES IN RELATION TO INFLAMMATORY BOWEL DISEASE;Pharmacology & Toxicology;1997-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3